文献速递产科母胎医学

不同孕周双胎妊娠宫颈长度≤15 mm行宫颈环扎术的临床效果分析

[Analysis of clinical effect of cervical cerclage in twin pregnancies with cervical length ≤15 mm at different gestational ages].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2025-01-01

回顾性队列研究纳入83例妊娠16~27+6周经阴道超声提示宫颈长度≤15 mm的双胎妊娠孕妇,分宫颈环扎组47例与保守治疗组36例。环扎组分娩孕周及延长孕周均大于保守组,34、32、28周前早产率更低;发现孕周<26周时环扎改善分娩孕周、新生儿体重、不良结局及活产率,≥26周时两组结局无显著差异。

要点

  • 宫颈长度≤15 mm双胎妊娠,环扎组中位分娩孕周35.3周 vs 保守组33.0周,34周前早产率23% vs 53%。
  • 发现孕周<26周时环扎组活产率100%(68/68) vs 保守组82%(28/34),新生儿不良结局19% vs 56%。
  • 发现孕周≥26周时两组妊娠结局均无统计学显著差异(P均>0.05)。

核心结论

  • 宫颈环扎术可能降低妊娠26周前宫颈长度≤15 mm双胎妊娠孕妇的早产风险并改善新生儿结局。
  • 妊娠26周及之后宫颈长度≤15 mm的双胎妊娠孕妇,宫颈环扎术未降低早产风险。

研究设计与样本

  • 本研究为回顾性队列研究,纳入2017年1月至2023年12月福建省妇幼保健院妊娠16~27+6周经阴道超声提示宫颈长度≤15 mm的双胎妊娠孕妇83例。
  • 按治疗方式分为宫颈环扎组47例与保守治疗组36例,并按宫颈长度≤15 mm发现孕周<26周、≥26周分层比较妊娠结局。
  • 采用多因素logistic回归分析宫颈环扎术对不同发现孕周双胎妊娠孕妇早产的影响。

主要发现

  • 环扎组中位分娩孕周35.3周 vs 保守组33.0周,中位延长孕周10.4周 vs 7.2周,环扎组均更长。
  • 34周前早产率环扎组23%(11/47) vs 保守组53%(19/36),32周前15%(7/47) vs 39%(14/36),28周前4%(2/47) vs 25%(9/36),环扎组均更低(P均<0.05)。
  • 37周前早产率及未足月胎膜早破率两组比较均无统计学显著差异(P均>0.05)。
  • 发现孕周<26周时,环扎组分娩孕周中位35.4周 vs 31.3周、延长孕周中位11.1周 vs 5.6周、新生儿出生体重(2 246±519)g vs(1 594±691)g、新生儿不良结局19%(13/68) vs 56%(19/34)、活产率100%(68/68) vs 82%(28/34),环扎组均更优(P均<0.05)。
  • 发现孕周≥26周时两组妊娠结局比较均无统计学显著差异(P均>0.05)。

关键数值与推荐

  • 发现孕周<26周时,宫颈环扎术降低34周前早产风险(aOR=0.10,95%CI 0.02~0.51,P<0.05)。
  • 发现孕周<26周时,宫颈环扎术降低32周前早产风险(aOR=0.11,95%CI 0.02~0.58,P<0.05)。
  • 发现孕周<26周时,宫颈环扎术降低28周前早产风险(aOR=0.04,95%CI 0.01~0.65,P<0.05)。
  • 发现孕周≥26周时,宫颈环扎术未降低34、32及28周前早产风险(P均>0.05)。

临床怎么用

  • 作者认为,宫颈环扎术可能降低妊娠26周前宫颈长度≤15 mm双胎妊娠孕妇的早产风险并改善新生儿结局。
  • 作者认为,妊娠26周及之后宫颈长度≤15 mm的双胎妊娠孕妇,宫颈环扎术未显示优于保守治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the clinical effect of cervical cerclage at different gestational weeks in twin pregnancy with cervical length (CL)≤15 mm. Methods: This was a retrospective cohort study. Eighty-three twin pregnant women with CL≤15 mm detected by transvaginal ultrasound at 16-27+6 weeks of gestation in Fujian Maternity and Child Health Hospital from January 2017 to December 2023 were enrolled. According to different treatment methods, they were divided into cervical cerclage group (47 cases) and conservative treatment group (36 cases), and stratified according to the gestational age of CL≤15 mm diagnosis (<26 weeks, ≥26 weeks). The differences in pregnancy outcomes between the two groups were compared. Multivariate logistic regression was used to analyze the effect of cervical cerclage on preterm birth in twin pregnant women with different CL≤15 mm diagnosis weeks. Results: (1) The gestational age at delivery and prolonged gestational age in the cervical cerclage group were longer than those in the conservative treatment group (median gestational age at delivery: 35.3 vs 33.0 weeks; median prolonged gestational age: 10.4 vs 7.2 weeks), and preterm birth rates before 34, 32 and 28 weeks were lower than those in the conservative treatment group [34 weeks: 23% (11/47) vs 53% (19/36); 32 weeks: 15% (7/47) vs 39% (14/36); 28 weeks: 4% (2/47) vs 25% (9/36)], the differences were statistically significant (all P<0.05). There were no significant differences in the rates of preterm birth before 37 weeks of gestation and preterm premature rupture of membranes between the two groups (all P>0.05). (2) When gestational age at CL≤15 mm diagnosis was <26 weeks, pregnancy outcomes in the cervical cerclage group were better than those in the conservative treatment group, including gestational age at delivery (median: 35.4 vs 31.3 weeks) and prolonged gestational age (median: 11.1 vs 5.6 weeks), neonatal birth weight [(2 246±519) vs (1 594±691) g], incidence of adverse neonatal outcomes [19% (13/68) vs 56% (19/34)], and proportion of live births [100% (68/68) vs 82% (28/34)], respectively; the differences were statistically significant (all P<0.05). When the gestational age of CL≤15 mm diagnosis was ≥26 weeks, there were no statistically significant difference in pregnancy outcomes between the two groups (all P>0.05). (3) Multivariate logistic regression analysis showed that when the gestational age of CL≤15 mm diagnosis was <26 weeks, cervical cerclage reduced the risk of preterm birth before 34 weeks (aOR=0.10, 95%CI: 0.02-0.51; P<0.05), 32 weeks (aOR=0.11, 95%CI: 0.02-0.58; P<0.05) and 28 weeks (aOR=0.04, 95%CI: 0.01-0.65; P<0.05). When the gestational age of CL≤15 mm diagnosis was ≥26 weeks, cervical cerclage did not reduce the risk of preterm birth before 34, 32 and 28 weeks of gestation (all P>0.05). Conclusions: Cervical cerclage might reduce the risk of preterm birth and improve neonatal outcomes in twin pregnancies with CL≤15 mm before 26 weeks. However, cerclage showed no advantage over conservative treatment in twin pregnancies with CL≤15 mm over 26 weeks. 目的: 探讨子宫颈长度(CL)≤15 mm双胎妊娠孕妇不同孕周行子宫颈环扎术的临床疗效。 方法: 本研究为回顾性队列研究,纳入2017年1月至2023年12月在福建省妇幼保健院产前检查,妊娠16~27+6周经阴道超声检查提示CL≤15 mm的双胎妊娠孕妇83例,根据治疗方式不同分为子宫颈环扎组(47例)和保守治疗组(36例),并根据CL≤15 mm发现孕周分层(<26周、≥26周),比较两组孕妇妊娠结局的差异。采用多因素logistic回归分析子宫颈环扎术对不同孕周双胎妊娠孕妇早产的影响。 结果: (1)子宫颈环扎组孕妇分娩孕周、延长孕周均大于保守治疗组(中位分娩孕周分别为35.3、33.0周;中位延长孕周分别为10.4、7.2周),妊娠34、32及28周前早产率均低于保守治疗组[34周前早产率分别为23%(11/47)、53%(19/36);32周前早产率分别为15%(7/47)、39%(14/36);28周前早产率分别为4%(2/47)、25%(9/36)],分别比较,差异均有统计学意义(P均<0.05)。两组孕妇妊娠37周前早产率及未足月胎膜早破率分别比较,差异均无统计学意义(P均>0.05)。(2)CL≤15 mm发现孕周<26周时,子宫颈环扎组的妊娠结局均优于保守治疗组,包括分娩孕周(中位数分别为35.4、31.3周)、延长孕周(中位数分别为11.1、5.6周)、新生儿出生体重[分别为(2 246±519)、(1 594±691)g]、新生儿不良结局发生率[分别为19%(13/68)、56%(19/34)]、活产率[分别为100%(68/68)、82%(28/34)],分别比较,差异均有统计学意义(P均<0.05)。CL≤15 mm发现孕周≥26周时,两组孕妇妊娠结局比较,差异均无统计学意义(P均>0.05)。(3)多因素logistic回归分析显示,CL≤15 mm发现孕周<26周时,子宫颈环扎术可能降低双胎妊娠孕妇妊娠34周(aOR=0.10,95%CI为0.02~0.51)、32周(aOR=0.11,95%CI为0.02~0.58)、28周(aOR=0.04,95%CI为0.01~0.65)前的早产风险(P均<0.05)。当CL≤15 mm发现孕周≥26周时,子宫颈环扎术均不能降低双胎妊娠孕妇妊娠34、32及28周前的早产风险(P均>0.05)。 结论: 子宫颈环扎术可降低妊娠26周前CL≤15 mm双胎妊娠孕妇的早产风险,改善新生儿结局。而对于妊娠26周及之后CL≤15 mm的双胎妊娠孕妇,子宫颈环扎术并未降低早产风险。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang LH, Pan M. [Analysis of clinical effect of cervical cerclage in twin pregnancies with cervical length ≤15 mm at different gestational ages]. Zhonghua Fu Chan Ke Za Zhi. 2025. PMID: 40010794. doi:10.3760/cma.j.cn112141-20241018-00560

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。